Table of Contents PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Pharmaceutical manufacturing outsourcing • Increased regulatory guidelines coupled with healthcare cost containment efforts • Rapid innovation and reduced product development lifecycle • High capital investment PART 06: Market landscape • Market overview • Five forces analysis PART 07: Market segmentation by type of contract manufacturing • Global API/bulk drug contract manufacturing market • Global FDF market PART 08: Geographical segmentation • Global pharmaceutical contract manufacturing market by geography • Pharmaceutical contract manufacturing market in Americas • Pharmaceutical contract manufacturing market in APAC • Pharmaceutical contract manufacturing market in EMEA PART 09: Key leading countries PART 10: Market drivers • Increased focus on core competence • High number of US FDA-approved manufacturing facilities in emerging countries • Shorter time-to-market PART 11: Impact of drivers PART 12: Market challenges • Capacity utilization issues and lack of information integration • Growing global competition • Lack of manufacturing standardization PART 13: Impact of drivers and challenges PART 14: Market trends • Consolidation through vertical integration, alliances, and acquisitions • Huge demand for next-generation biologics • Value-added services PART 15: Vendor landscape • Competitive scenario PART 16: Key vendor analysis • Catalent • Lonza • Pfizer CentreOne • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio   List of Exhibits Exhibit 01: Service offerings Exhibit 02: Overview of global pharmaceutical contract manufacturing market Exhibit 03: Global pharmaceutical contract manufacturing market: Present and future scenario Exhibit 04: Process of drug development Exhibit 05: Value chain of pharmaceutical industry Exhibit 06: Contract manufacturing market: Benefit analysis Exhibit 07: Factors affecting pharmaceutical manufacturing outsourcing Exhibit 08: Key factors and its impact on selection of CMOs Exhibit 09: Global pharmaceutical contract manufacturing market: Market overview Exhibit 10: CMO market growth Exhibit 11: Overview of outsourced new drug abbreviations (NDAs) in CMO industry Exhibit 12: Cost comparison of drug development in the US and India Exhibit 13: Global pharmaceutical contract manufacturing market 2015-2020 ($ billions) Exhibit 14: Average number of services outsourced by company type 2013-2015 Exhibit 15: Preference for choosing pharmaceutical outsourcing partners Exhibit 16: Factors affecting the global pharmaceutical contract manufacturing market Exhibit 17: Opportunities analysis: Global pharmaceutical contract manufacturing market Exhibit 18: Growth of global pharmaceutical contract manufacturing market 2016-2020 Exhibit 19: Five forces analysis Exhibit 20: Market segmentation based on type of contract manufacturing Exhibit 21: Segment outlook Exhibit 22: Market overview of global API/bulk drug manufacturing market Exhibit 23: Global API/bulk drug contract manufacturing market 2015-2020 ($ billions) Exhibit 24: Global API/bulk drug contract manufacturing market Exhibit 25: Overview of API outsourcing manufacturing market Exhibit 26: Market share of global FDF market 2015 Exhibit 27: Types of dosage forms Exhibit 28: Lifecycle analysis of dosage formulations Exhibit 29: Global FDF market 2015-2020 ($ billions) Exhibit 30: Market share of global pharmaceutical contract manufacturing market 2015 Exhibit 31: Global pharmaceutical contract manufacturing market: Geography outlook 2015-2020 Exhibit 32: Global pharmaceutical contract manufacturing market: Current and future impact Exhibit 33: Pharmaceutical contract manufacturing market in Americas 2015-2020 ($ billions) Exhibit 34: Pharmaceutical contract manufacturing market in APAC 2015-2020 ($ billions) Exhibit 35: Pharmaceutical contract manufacturing market in EMEA 2015-2020 ($ billions) Exhibit 36: Key leading countries Exhibit 37: Impact of drivers and challenges on global pharmaceutical contract manufacturing market Exhibit 38: Competitive advantage Exhibit 39: Examples of global pharmaceutical companies sourcing from CMOs Exhibit 40: Impact of drivers Exhibit 41: Capacity constraints by stage production 2015 Exhibit 42: Impact of drivers and challenges Exhibit 43: Impact of trends on global pharmaceutical contract manufacturing market Exhibit 44: Major M&A in global pharmaceutical contract manufacturing market Exhibit 45: Key vendors: Geographical presence 2015 Exhibit 46: Catalent: Profile Exhibit 47: Catalent: Metrics analysis Exhibit 48: Catalent: Growth strategy matrix Exhibit 49: Catalent: Opportunity assessment Exhibit 50: Lonza: Profile Exhibit 51: Lonza: Metrics analysis Exhibit 52: Lonza: Growth strategy matrix Exhibit 53: Lonza: Opportunity assessment Exhibit 54: Pfizer CentreOne: Profile Exhibit 55: Pfizer CentreOne profile: Metrics analysis Exhibit 56: Pfizer CentreOne: Growth strategy matrix Exhibit 57: Pfizer CentreOne: Growth opportunity assessment

Catalent, Lonza, Pfizer CentreOne, Abbott, Aenova, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, BERLIN-CHEMIE, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Cipla, Coherus Biosciences, Daiichi Sankyo, Dr. Reddy's Laboratories, Eli Lilly, Emcure Pharmaceuticals, Eurofarma Laboratories, Fareva, Gedeon Richter, Gilead Sciences, GlaxoSmithKline (GSK),Hospira, Impax Laboratories, Intas Pharmaceuticals, Janssen Pharmaceuticals, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus Pharmaceuticals, Novo Nordisk, Orchid Chemicals & Pharmaceuticals, Par Pharmaceutical, Parenteral Drugs India, Patheon, Piramal, Roche Holding, Sanofi, Synthon, Teva Pharmaceuticals, Valeant Pharmaceuticals, Zentiva, Zhejiang Huahai Pharmaceutical, Zydus Cadila.